Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients of both genders~* Age ≥ 18 years~* Diagnosed with systolic HF~* Able to monitor body weight at home~* Using furosemide~Exclusion Criteria:~* Those who are not able to make return visits or participate in telephone contact, and those on renal replacement therapy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: ACTIVE_COMPARATOR): In the control group, patients just diuretic adjusted (Furosemide 40 milligrams) by the doctor on the baseline. The patients do not receive phone calls neither advising on non-pharmacological treatment; The medication is adjusted by the doctor during the initial evaluation of study baseline.
- Furosemide and Phone contact (Type: EXPERIMENTAL): The intervention group is conducted by a nurse in a systematic way during one time per week. If signs and symptoms of congestion, the dose of diuretic ( furosemide ) is revised , nonpharmacological guidelines are provided. According to the algorithm 1KG weight changes are indicative of modifying the diuretic dose , with the addition or reduction 1 tablet a day.

Based on this trial design, predict the completion outcome and termination type (if applicable).